American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Perales
    Perales
  5. Tallman
    Tallman
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Palomba
    Palomba
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3996)
  2. Hematologic Malignancies, Division of (3799)
  3. Center for Hematologic Malignancies (3676)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)
  7. Bone Marrow Transplant (985)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (955)
  9. Lymphoma (940)
  10. Tow Center for Developmental Oncology (TCDO) (882)
Search Within
Formats
  1. Meeting Abstract (4150)
  2. Journal Article (1252)
  3. Research Letter (46)
  4. Review (44)
  5. Editorial (35)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3996)
  2. Hematologic Malignancies, Division of (3799)
  3. Center for Hematologic Malignancies (3676)
  4. GSK Faculty (1590)
  5. Adult Leukemia (1341)
  6. Sloan Kettering Institute Faculty (1075)

More Groups

People
  1. Sergio Giralt (348)
  2. Andrew Zelenetz (341)
  3. Ross Levine (316)
  4. Miguel-Angel Perales (311)
  5. Martin Tallman (301)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (59)
  2. 2024 (428)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5169)
  2. Blood Advances (331)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5550)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • AUY922, a Heat Shock Protein 90 (Hsp90) inhibitor, demonstrates activity in patients with myeloproliferative neoplasms (MPNs)
    Meeting Abstract

    Hobbs, G.; Litvin, R.; Ahn, J.; McKenney, A. S.; Mauro, M. J.; Tallman, M. S.; Berman, E.; Heaney, M. L.; Levine, R. L.; Rampal, R. K.
    Blood (2015)

    Fulltext@MSK | Save
  • Erwinia asparaginase safety and feasibility during therapy for acute lymphoblastic leukemia in adult patients with pegaspargase hypersensitivity or severe toxicity
    Meeting Abstract

    Horvat, T. Z.; Pecoraro, J. J.; Daley, R. J.; Buie, L. W.; Douer, D.
    Blood (2015)

    Fulltext@MSK | Save
  • Infection burden of double stranded DNA (dsDNA) viruses after CD34(+) selected, T-cell depleted (TCD) hematopoietic cell transplantation (HCT) for myeloid malignancies at Memorial Sloan Kettering Cancer Center (MSK)
    Meeting Abstract

    Huang, Y. T. H.; Kim, S. J.; Lee, Y. J.; Burack, D.; Nichols, P.; Maloy, M.; Tamari, R.; Perales, M. A.; Giralt, S. A.; Castro-Malaspina, H. R.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Phase 1 trial of targeted alpha-particle immunotherapy with actinium-225 ((225)Ac)-lintuzumab (Anti-CD33) and low-dose cytarabine (LDAC) in older patients with untreated acute myeloid leukemia (AML)
    Meeting Abstract

    Jurcic, J. G.; Ravandi, F.; Pagel, J. M.; Park, J. H.; Smith, B. D.; Levy, M. Y.; Estey, E. H.; Perl, A. E.; Kantarjian, H.; Earle, D.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Defibrotide for the treatment of patients with hepatic veno-occlusive disease/sinusoidal obstruction syndrome with/without multi-organ dysfunction following chemotherapy: Results from an ongoing expanded access program
    Meeting Abstract

    Kernan, N. A.; Richardson, P. G.; Smith, A. R.; Triplett, B. M.; Grupp, S. A.; Antin, J. H.; Lehmann, L. E.; Liang, W.; Hume, R. L.; Hannah, A. L.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Pooled treatment analysis of pediatric patients with defibrotide for hepatic veno-occlusive disease/sinusoidal obstruction syndrome and multi-organ dysfunction following hematopoietic stem cell transplant
    Meeting Abstract

    Kernan, N. A.; Grupp, S. A.; Banerjee, K.; Hannah, A. L.; Hume, R. L.; Nejadnik, B.; Richardson, P.
    Blood (2015)

    Fulltext@MSK | Save
  • T-cell depleted peripheral blood stem cell (TCD-PBSC) transplants secure consistent engraftment with low risk of acute or chronic Gvhd and favorable disease free survival (DFS) and overall survival (OS) for pediatric patients (<21 years) with AML in CR1 or CR2 or MDS including tMDS/AML
    Meeting Abstract

    Kernan, N. A.; Boulad, F.; Prockop, S.; Wolden, S.; Scaradavou, A.; Kobos, R.; Lehrman, R.; Klein, E.; Curran, K. J.; Hasan, A. N.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Mir-99 is a regulator of hematopoietic and leukemic stem cell differentiation
    Meeting Abstract

    Khalaj, M.; Hu, W.; Park, C. Y.
    Blood (2015)

    Fulltext@MSK | Save
  • Age-adjusted co-morbidity core - but not revised Disease Risk Index - is associated with progression-free survival after intermediate intensity double unit CBT in adults with hematologic malignancies
    Meeting Abstract

    Kosuri, S.; Hilden, P.; Devlin, S.; Yoo, Y.; Lauer, E.; Peled, J.; Dahi, P. B.; Giralt, S. A.; Gyurkocza, B.; Castro-Malaspina, H.; more...
    Blood (2015)

    Fulltext@MSK | Save
  • Platelet function disorders in bleeding patients without other coagulopathies
    Meeting Abstract

    Dembitzer, F. R.; Peerschke, E. I. B.; Cromwell, C.; Zhang, X. F.; Aledort, L. M.
    Blood (2015)

    Fulltext@MSK | Save